FDA/CDC

Arsenic levels in infant rice cereal are down


 

Infant rice cereal contains lower levels of arsenic than it did in 2014, according to test results released by the Food and Drug Administration.

FDA icon

In April 2016, the FDA issued draft guidance calling for manufacturers of the product to reduce the level of arsenic in their cereals by establishing an action level of arsenic of 100 mcg/kg or 100 parts per billion.

Seventy-six percent of samples of infant rice cereal tested in 2018 had levels of arsenic at or below 100 parts per billion versus 47% of samples tested in 2014, according to a statement from the FDA. In 2011-2013, an even lower percentage of samples tested contained amounts of inorganic arsenic at or below the FDA’s current action level for this element, whose consumption has been associated with cancer, skin lesions, cardiovascular diseases, and diabetes.

The 2018 data is based on the testing of 149 samples of infant white and brown rice cereal samples.

“Results from our tests show that manufacturers have made significant progress in ensuring lower levels of inorganic arsenic in infant rice cereal,” Susan Mayne, PhD, director of the Center for Food Safety and Applied Nutrition, said in the FDA statement.

“Both white rice and brown rice cereals showed improvement in meeting the FDA’s 100 ppb proposed action level, but the improvement was greatest for white rice cereals, which tend to have lower levels of inorganic arsenic overall,” according to the statement.

Recommended Reading

How to reduce NICU transfers for asymptomatic hypoglycemia
MDedge Endocrinology
MDedge Daily News: Why most heart failure may be preventable
MDedge Endocrinology
MDedge Daily News: Fewer smokes mean fewer strokes
MDedge Endocrinology
Research provides more evidence of a maternal diabetes/autism link
MDedge Endocrinology
Risk of adverse birth outcomes for singleton infants born to ART-treated or subfertile women
MDedge Endocrinology
Endocrine Society updates guidelines for congenital adrenal hyperplasia
MDedge Endocrinology
Levonorgestrel implant right after delivery does not affect breastfeeding, infant growth
MDedge Endocrinology
Insulin-treated diabetes in pregnancy carries preterm risk
MDedge Endocrinology
Twin births down among women 30 and older
MDedge Endocrinology
Poor neonatal outcomes tied to excessive, insufficient weight gain during twin pregnancies
MDedge Endocrinology